Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications
A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare condition involving reduced blood flow to the optic nerve that can cause…
Read the full articleYou might also wanna read
Study Probes Absolute Risk for ION With GLP-1 Agents
In patients with type 2 diabetes, GLP-1 RAs may be associated with a higher incidence of ischemic optic neuropathy than other medications, c
GLP-1s and Blinding Condition; Cyclosporiasis Source Found? Tylenol-Autism Lawsuits
(MedPage Today) -- Note that some links may require registration or subscription. A cohort study found that diabetes patients taking GLP-1 r
GLP-1 Receptor Agonists and Eye Safety: Examining the NAION Risk at ADA 2025
Do their associations with nonarteritic anterior ischemic optic neuropathy and other adverse outcomes make these drugs more risky than benef
mdsc.pe·18h ago
GLP-1 drugs tied to elevated risk of low blood pressure episodes
Study of 42,000 adults taking blood pressure meds found increased rates of hypotension, dizziness and fainting
Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk
“Whiplash”: Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s: Stopping GLP-1 treatments has side effects, too
nautil.us·3mo ago
GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes
The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associate
mdsc.pe·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.